How Amorphous Nanomaterials Enhanced Electrocatalytic, SERS, and Mechanical Properties
JACS Au · 23.10.2023 · 3 (10) · 2660-2676
DOI: 10.1021/jacsau.3c00418 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JACS Au, online erschienen am 08.10.2023. Verfasst von Jianxin Kang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Beijing Advanced Innovation Center for Biomedical Engineering, Key Laboratory of Bio-Inspired Smart Interfacial Science and Tech…. Die Arbeit wurde bisher 87-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- School of Chemistry, Beijing Advanced Innovation Center for Biomedical Engineering, Key Laboratory of Bio-Inspired Smart Interfacial Science and Technology, Beihang University, Beijing 100191, China.
- Research Institute for Frontier Science, Beihang University, Beijing 100191, China.
ORCID-Profile: Fengshi Li, Lin Guo
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Kang, J., Li, F., Xu, Z., Chen, X., Sun, M., Li, Y., Yang, X., & Guo, L. (2023). How Amorphous Nanomaterials Enhanced Electrocatalytic, SERS, and Mechanical Properties. JACS Au, 3(10), 2660-2676. https://doi.org/10.1021/jacsau.3c00418
Vancouver
Kang J, Li F, Xu Z, Chen X, Sun M, Li Y, et al. How Amorphous Nanomaterials Enhanced Electrocatalytic, SERS, and Mechanical Properties. JACS Au. 2023;3(10):2660-2676. doi:10.1021/jacsau.3c00418
BibTeX
@article{Kang2023,
author = {Kang, Jianxin and Li, Fengshi and Xu, Ziyan and Chen, Xiangyu and Sun, Mingke and Li, Yanhong and Yang, Xiuyi and Guo, Lin},
title = {How Amorphous Nanomaterials Enhanced Electrocatalytic, SERS, and Mechanical Properties},
journal = {JACS Au},
year = {2023},
volume = {3},
number = {10},
pages = {2660--2676},
doi = {10.1021/jacsau.3c00418}
}
EUVIMED